Results 161 to 170 of about 41,188 (289)

Unveiling relative lymphopenia and elevated monocyte‐to‐lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)—Proposal of the objective prognostic index for CMML (OPIC)

HemaSphere, Volume 10, Issue 1, January 2026.
Abstract Chronic myelomonocytic leukemia (CMML) shows marked prognostic heterogeneity. Although leukocytosis is a recognized adverse prognostic factor, the contribution of its individual components remains insufficiently defined. In a cohort of 240 patients classified according to International Consensus Classification (ICC) and World Health ...
Xavier Calvo, Abora Rial‐Villavecchia, David Roman‐Bravo, Sara Garcia‐Avila, Lucia Gomez‐Perez, Marta Salido, Anna Puiggros, Blanca Espinet, Concepcion Fernandez‐Rodriguez, Barbara Tazon‐Vega, Beatriz Bellosillo, Sandra Castaño‐Díez, Marina Díaz‐Beyá, Jordi Esteve, Carmen Lome, Lluis Colomo, Lourdes Florensa, Ana Ferrer del Álamo, Juan Jose Rodriguez‐Sevilla, Leonor Arenillas   +19 more
wiley   +1 more source

Non‐invasive imaging of retinal blood flow in myeloproliferative neoplasms [PDF]

, 2016
Anne Willerslev, Mathias Møller Hansen, Oliver Niels Klefter, Ole Weis Bjerrum, Hans Carl Hasselbalch, Stine Novrup Clemmensen, Michael Larsen, Inger Christine Munch   +7 more
openalex   +1 more source

The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: “Crafting” a Microenvironment That Matters [PDF]

, 2021
Lucia Catani, Michèle Cavo, Francesca Palandri   +2 more
openalex   +1 more source

Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial

Hematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT Primary myelofibrosis (PMF) is a chronic myeloproliferative neoplasm characterized by the activation of the JAK‐STAT pathway. Previous evidence showed that metformin might be a possible therapeutic option for treating JAK2‐mediated myeloproliferative neoplasms.
Paula de Melo Campos, Kátia Borgia Barbosa Pagnano, Fernanda Soares Niemann, Rubia Isler Mancuso, Fernanda Isabel Della Via, Ada Congrains, Juan Luiz Coelho‐Silva, Ângela Condotta Tinoco, Guilherme Rossi Assis‐Mendonça, Leandro Luiz Lopes de Freitas, Fabiola Traina, Sara T. Olalla Saad   +11 more
wiley   +1 more source

Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India

, 2018
Nikhil Rabade, PG Subramanian, Rohan Kodgule, Goutham Raval, Swapnali Joshi, Shruti Chaudhary, Russel Mascarenhas, Prashant Tembhare, Sumeet Gujral, Nikhil Patkar   +9 more
openalex   +1 more source

Myeloproliferative neoplasms, thrombosis and paroxysmal nocturnal hemoglobinuria: Is this triad more frequent than we thought? [PDF]

, 2017
V Gaidano, Massimo Geuna, A Cignetti, Francesca Carnuccio, P. A. Bernabei, Nicola Santoro, Giuseppe Saglio, Piera Sivera   +7 more
openalex   +1 more source

Patient and Family Demographics in the Momcology Pediatric Cancer Patient Advocacy Organization

Pediatric Blood &Cancer, Volume 73, Issue 1, January 2026.
ABSTRACT Background Momcology is a US‐based patient advocacy organization that provides support for families of children with cancer. This study describes Momcology for researchers by detailing the demographic, clinical, and socioeconomic (socioeconomic status [SES]) data within its registry and comparing it to the National Surveillance, Epidemiology ...
Ryan Salama, Alexis Shuck, Zhanni Lu, Kimberly Buff, Michelle A. Roesler, Catherine Paciente, Logan G. Spector   +6 more
wiley   +1 more source

CHEK2 Germline Variants in Early‐Onset and Familial Myeloproliferative Neoplasms [PDF]

Oscar Borsani, Elisabetta Molteni, Daniela Pietra, Anna Gallì, Virginia Valeria Ferretti, Silvia Catricalà, Ettore Rizzo, Luca Malcovati, Elisa Rumi   +8 more
openalex   +1 more source

Integrated Use of Oxidative Stress and Histological Biomarkers of T. tinca as Indicators of 17‐Alpha‐Ethynylestradiol Exposure

Environmental Toxicology, Volume 41, Issue 1, Page 49-67, January 2026.
ABSTRACT The potential adverse effects of 17‐alpha‐ethynylestradiol (50, 100, and 500 μg EE2/kg b.w., for 30 days) on tench ( Tinca tinca ) were evaluated by integrating biomarkers including physiological (hepato‐somatic index, spleen‐somatic index, and hematocrit), oxidative stress (catalase, glutathione peroxidase, and glutathione reductase ...
Ana L. Oropesa, Alfonso Ramos, Cesar Fallola, Luis J. Gomez   +3 more
wiley   +1 more source

MDS/MPN With SF3B1 Mutation and Thrombocytosis but Without Ring Sideroblasts

American Journal of Hematology, Volume 101, Issue 1, Page 129-130, January 2026.
Biswadip Hazarika, Barbara J. Bain
wiley   +1 more source